EVH Overview

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Wall Street analysts forecast EVH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EVH is9.33 USD with a low forecast of 5.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Evolent Health Inc revenue for the last quarter amounts to 496.25M USD, increased 2.60

Evolent Health Inc. EPS for the last quarter amounts to -0.24 USD, decreased -61.90

Evolent Health Inc (EVH) has 4200 emplpoyees as of May 11 2026.

Today EVH has the market capitalization of 470.17M USD.